Revolution Medicines Stock News & Updates
[WKN: A2PYWG | Symbol: RVMD]Analysts' Top 5 Price Targets of April 14, 2026
Stocks in Action USA: IDEAYA Biosciences, Leggett & Platt, Revolution Medicines
IDEAYA Biosciences (IDYA) – Oncology specialist achieves clinical breakthrough: Stock explosion after...
Geopolitical Shock Hits Earnings Season – Oil Price Above $100 Dims Rate cut Hopes – Biotech Breakthroughs Boost Individual Stocks - IDEAYA Biosciences with an Oncology Game Changer – SanDisk, Intel, and Lightwave Reach new 52-Week Highs
USA & MACRO SITUATION Wall Street starts the new trading week with noticeable losses in a geopolitical...
Revolution Medicine: Targeting Cancer Mutation and the Billion-Dollar Potential of RAS Inhibitors
Revolution Medicine is a global leader in the development of RAS(ON) inhibitors, which, unlike traditional...
Trump Threatens Canada with 100% Tariffs in Case of China Deal - Shutdown Risk Surges to 80% - Winter Chaos in the US Causes Power Outages and Flight Cancellations - Gold Over $5,000 - USA Rare Earth Receives $1.6 Billion Government Stake - DeepMind CEO Warns Investors - Samsung on HBM4 Certification - Huang Travels to China - Merck Aborts Acquisition of Revolution Medicines
On Friday, January 23, 2026, US markets ended mixed as they recorded their second consecutive losing...
Analysts' Top 5 Price Targets of January 23, 2026
Revolution Medicines [US76155X1000] Stifel reaffirms Buy rating and simultaneously doubles the price...
Revolution Medicines - Biotech Company Targeted by Merck & Co!
Business Driver: Revolution Medicines (RVMD) specializes in developing new therapies for the treatment...
DAX ahead of US jobs report with slight gains - Puma in focus after takeover speculation - Auto1 Group benefits from Goldman study - Teamviewer in demand after figures - Bloom Energy benefits from billion-dollar contract - Revolution Medicines with stock fireworks after acquisition rumors
The DAX is exhibiting strength again at the end of the new trading week and can thus build on the strong...
TOP-5 Analyst Price Targets as of October 16, 2025
Revolution Medicines [US76155X1000] Stifel has resumed coverage with a "Buy" rating and a price...
Revolution Medicines - The Biotech Company Impresses with a Strong Pipeline!
Business drivers: Revolution Medicines (RVMD) specializes in the development of new therapeutic approaches...
Analysts' Top 5 Price Targets of September 11, 2025
Heidelberg Materials AG [DE0006047004] JPMorgan reaffirms rating as Overweight and raises the price...
Revolution Medicines: LifeSci Capital Sees 85% Price Potential - The Well-Structured Study for Pancreatic Cancer was Highlighted Positively
Revolution Medicines (RVMD) is a biopharmaceutical company that specializes in the development of targeted...